Evidence map›Paper›PMID 25222913›Full record

ArticleMolecular medicine (Cambridge, Mass.)2015

Hydrogen sulfide alleviates myocardial collagen remodeling in association with inhibition of TGF-β/Smad signaling pathway in spontaneously hypertensive rats.

Lili Sun, Hongfang Jin, Lujing Sun, Siyao Chen, Yaqian Huang, Jia Liu, Zhenzhen Li, Manman Zhao, Yan Sun, Chaoshu Tang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Growth factors in the treatment of Achilles tendon injury.Frontiers in bioengineering and biotechnology · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Hydrogen sulfide and vascular regulation - An update.Journal of advanced research · 2021
    Review
  11. Hydrogen sulfide signaling in mitochondria and disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis.International journal of molecular sciences · 2018
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Lili SunDepartment of Emergency Medicine, Beijing Jishuitan Hospital, Beijing, China.
Hongfang JinDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Lujing SunDepartment of Emergency Medicine, Beijing Jishuitan Hospital, Beijing, China.
Siyao ChenDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Yaqian HuangDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Jia LiuDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Zhenzhen LiDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Manman ZhaoDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Yan SunDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Chaoshu TangDepartment of Physiology and Pathophysiology, Peking University Health Science Center, Beijing, China.
Bin ZhaoDepartment of Emergency Medicine, Beijing Jishuitan Hospital, Beijing, China.
Junbao DuDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Peking University · CNPeking University First Hospital · CNBeijing Jishuitan Hospital · CNBeijing Anzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study was designed to explore the role and possible mechanisms of hydrogen sulfide (H2S) in the regulation of myocardial collagen remodeling in spontaneously hypertensive rats (SHRs). We treated nine-week-old male SHRs and age- and sex-matched Wistar-Kyoto rats (WKYs) with NaHS (90 μmol/kg(-1)·day(-1)) for 9 wks. At 18 wks, plasma H2S, tail arterial pressure, morphology of the heart, myocardial ultrastructure and collagen volume fraction (CVF), myocardial expressions of collagen I and III protein and procollagen I and III mRNA, transforming growth factor-β1 (TGF-β1), TGF-β type I receptor (TβR-I), type II receptor (TβR-II), p-Smad2 and 3, matrix metalloproteinase (MMP)-13 and tissue inhibitors of MMP (TIMP)-1 proteins were determined. TGF-β1-stimulated cultured cardiac fibroblasts (CFs) were used to further study the mechanisms. The results showed that compared with WKYs, SHRs showed a reduced plasma H2S, elevated tail artery pressure and increased myocardial collagen, TGF-β1, TβR-II, p-Smad2 and p-Smad3 expressions. However, NaHS markedly decreased tail artery pressure and inhibited myocardial collagen, TGF-β1, TβR-II, p-Smad2 and p-Smad3 protein expressions, but H2S had no effect on the expressions of MMP-13 and TIMP-1. Hydralazine reduced blood pressure but had no effect on myocardial collagen, MMP-13 and TIMP-1 expressions and TGF-β1/Smad signaling pathway. H2S prevented activation of the TGF-β1/Smad signaling pathway and abnormal collagen synthesis in CFs. In conclusion, the results suggested that H2S could prevent myocardial collagen remodeling in SHR. The mechanism might be associated with inhibition of collagen synthesis via TGF-β1/Smad signaling pathway.

Indexed as

AnimalsArterial PressureCells, CulturedCollagen Type ICollagen Type IIIFibroblastsHydrogen SulfideHypertensionMaleMicroscopy, Electron, TransmissionMyocardiumProtein Serine-Threonine KinasesRats, Inbred SHRRats, Inbred WKYRats, Sprague-DawleyReceptors, Transforming Growth Factor betaCollagen Type ICollagen Type IIIHydrogen SulfideProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IReceptor, Transforming Growth Factor-beta Type IISmad2 ProteinSmad2 protein, ratSmad3 ProteinSmad3 protein, ratsodium bisulfideSulfidesTgfbr1 protein, ratTransforming Growth Factor beta

Identifiers

PMID25222913
PMCPMC4365062
OpenAlexW2345432299

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.